307 results on '"Starzyńska, Teresa"'
Search Results
2. A fuzzy interval model for assessing patient status and treatment effectiveness using blood morphology
3. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
4. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study
5. Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study
6. Cerebral venous sinus thrombosis in a young patient with ulcerative colitis: A case report
7. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas-A Preliminary Study
8. Management of small, asymptomatic, non-functioning pancreatic neuroendocrine tumours: follow-up, ablation, or surgery?
9. Rectal neuroendocrine tumors in a colon cancer screening colonoscopy program. Sixteen-year single institution experience
10. Evidence of Stem Cells Mobilization in the Blood of Patients with Pancreatitis: A Potential Link with Disease Severity
11. Progression risk factors of ulcerative proctitis
12. Gastroduodenal neuroendocrine neoplasms including gastrinoma — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma — uaktualnione zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
13. Colorectal neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita grubego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]
14. Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
15. Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
16. Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]
17. Rectal neuroendocrine tumors in a colon cancer screening colonoscopy program. Sixteen-year single institution experience.
18. Management of small, asymptomatic, non-functioning pancreatic neuroendocrine tumours: follow-up, ablation, or surgery?
19. Endoscopic submucosal dissection for treatment of gastric subepithelial tumors (with video)
20. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells
21. An unusual cause of abdominal pain
22. Yersiniosis: a forgotten mimicker and confounder of Crohn’s disease
23. Acute portal vein thrombosis secondary to COVID-19
24. Nuclear Pedigree Criteria for the Identification of Individuals Suspected to Be at Risk of an Inherited Predisposition to Gastric Cancer
25. The gastric microbiota in patients with Crohn’s disease; a preliminary study
26. 102 zagadki ultrasonograficzne
27. The risk of gastric cancer in carriers of CHEK2 mutations
28. A rare cause of chronic diarrhoea: a diagnosis to keep in mind
29. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland
30. Nowotwory neuroendokrynne jelita grubego -- uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych).
31. Endoscopic treatment of rectal neuroendocrine tumors in a 13-year retrospective single-center study. Are we following the guidelines?
32. Analysis of clinicopathologic characteristics of gastric cancer in patients < or = 40 and > or = 40 years of age
33. Mutations and polymorphisms of genes moderate increase in gastric cancer risk
34. The CHEK 2 GENE mutations and the risk of Gastric cancer
35. Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients
36. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection
37. A small, yellowish nodule in the rectum: not as benign as it seems
38. Analysis of a cross-talk between various chemokines and bone marrow-derived stem cells in patients with pancreatic cancer: 252
39. An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer
40. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
41. Analysis of clinicopathologic characteristics of gastric cancer in patients ≤40 and ≥40 years of age
42. The Association Between the Interleukin-1 Polymorphisms and Gastric Cancer Risk Depends on the Family History of Gastric Carcinoma in the Study Population
43. Clinical analysis of selected complement-derived molecules in human adipose tissue
44. Clinical significance of endoscopic findings in the upper gastrointestinal tract in Crohn’s disease
45. Rare cause of massive gastrointestinal bleeding. A case of metastatic melanoma
46. Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine
47. Role of sonography in assessing complications after laparoscopic cholecystectomy
48. Neuroendocrine neoplasm of the colon in a patient with a severe relapse of ulcerative colitis. A case report.
49. Endoscopic management of rectal neuroendocrine tumours. How to avoid a mistake and what to do when one is made?
50. Analysis of clinicopathologic characteristics of gastric cancer in patients ≤40 and ≥40 years of age.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.